Department of Physiology, Seoul National University College of Medicine, Seoul, Korea.
J Biol Chem. 2012 Sep 14;287(38):31813-22. doi: 10.1074/jbc.M112.370601. Epub 2012 Jul 26.
Calcyon, once known for interacting directly with the dopamine D(1) receptor (D(1)DR), is implicated in various neuropsychiatric disorders including schizophrenia, bipolar disorder, and attention deficit hyperactivity disorder. Although its direct interaction with D(1)DR has been shown to be misinterpreted, it still plays important roles in D(1)DR signaling. Here, we found that calcyon interacts with the PSD-95 and subsequently forms a ternary complex with D(1)DR through PSD-95. Calcyon is phosphorylated on Ser-169 by the PKC activator phorbol 12-myristate 13-acetate or by the D(1)DR agonist SKF-81297, and its phosphorylation increases its association with PSD-95 and recruitment to the cell surface. Interestingly, the internalization of D(1)DR at the cell surface was enhanced by phorbol 12-myristate 13-acetate and SKF-81297 in the presence of calcyon, but not in the presence of its S169A phospho-deficient mutant, suggesting that the phosphorylation of calcyon and the internalization of the surface D(1)DR are tightly correlated. Our results suggest that calcyon regulates D(1)DR trafficking by forming a ternary complex with D(1)DR through PSD-95 and thus possibly linking glutamatergic and dopamine receptor signalings. This also raises the possibility that a novel ternary complex could represent a potential therapeutic target for the modulation of related neuropsychiatric disorders.
钙调蛋白曾经因其与多巴胺 D1 受体(D1DR)的直接相互作用而闻名,与各种神经精神疾病有关,包括精神分裂症、双相情感障碍和注意缺陷多动障碍。尽管已经表明其与 D1DR 的直接相互作用被误解,但它在 D1DR 信号转导中仍发挥着重要作用。在这里,我们发现钙调蛋白与 PSD-95 相互作用,随后通过 PSD-95 与 D1DR 形成三元复合物。钙调蛋白在丝氨酸 169 被蛋白激酶 C 激活剂佛波醇 12-肉豆蔻酸 13-醋酸盐或 D1DR 激动剂 SKF-81297 磷酸化,其磷酸化增加了与 PSD-95 的结合和募集到细胞膜表面。有趣的是,在钙调蛋白存在下,细胞膜表面 D1DR 的内化被佛波醇 12-肉豆蔻酸 13-醋酸盐和 SKF-81297 增强,但在其 S169A 磷酸缺陷突变体存在下没有增强,这表明钙调蛋白的磷酸化和表面 D1DR 的内化紧密相关。我们的结果表明,钙调蛋白通过与 PSD-95 形成三元复合物与 D1DR 调节 D1DR 转运,从而可能连接谷氨酸能和多巴胺受体信号。这也提出了一种新的三元复合物可能代表调节相关神经精神疾病的潜在治疗靶点的可能性。